High materiality9/10
Climb Bio price target raised to $20 from $19 at BTIG
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BTIG raises CLYM price target to $20 from $19.
- BTIG raises CLYM target to $20 (from $19).
Key facts
- 01
Target: $20
- 02
Posted price: $11.17
- 03
Analyst firm: BTIG
- 04
Analyst: Julian Harrison
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.